The outlook for the day is a flat to positive start on the back of cheerful cues from the Asian peers. At the time of writing, the SGX Nifty was up by 14 points at 11,353.

Out of last nine trading session, FIIs remained net seller in all of those sessions. The major indices are down  by more than 4 per cent. Read on to find if FIIs selling is related to such fall. 

The following stocks would be in focus during Tuesday’s trading session in light of their results announcement: CRISIL, DCM Shriram, Hindustan Unilever, L&T and Praj Industries.

Bharat Heavy Electricals (BHEL) has secured an order worth Rs. 486 crore for erection work of reactor side equipment of 2x1000 MWe (Units 3&4) Kudankulam Nuclear Power Project in Tamil Nadu which is being set up under foreign co-operation (Russia).

Alembic Pharmaceuticals has received approval from the US Food & Drug Administration (USFDA) for the company’s Abbreviated New Drug Application (ANDA) Pregabalin Capsules, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg.

The benchmark index extended losses by dipping 305.88 points or 0.80 per cent on Monday as HDFC twins and FMCG majors dragged the index, even as Reliance and TCS provided some support.

The stocks to watch out on July 23 include Allied Digital, KDDL, Lauras Labs, Can Fin Homes and ICICI Securities.

InvaGen Pharmaceuticals Inc, Cipla’s wholly-owned subsidiary has received final approval for its Abbreviated New Drug Application (ANDA) for Pregabalin Capsules.

Pregabalin is used to treat nerve pain in people with diabetes (diabetic neuropathy), herpes zoster (post-herpetic neuralgia), or spinal cord injury. The said medicine is also used with other medications to treat partial onset seizures in adults and children who are at least 4 years old.

Retirement planning is something which is generally a cornered topic in our country and many people have gathered myths regarding the same. So, what are the benefits of having a retirement plan? Let’s find out.